ClinicalTrialsFinder
RecruitingPhase 4NCT00768820

The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome

The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors

Sponsor

The Chaim Sheba Medical Center

Enrollment

400 participants

Start Date

May 1, 2001

Study Type

INTERVENTIONAL

Conditions

Williams SyndromeFragile X SyndromeVelocardiofacial Syndrome

Summary

The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors

Eligibility

Inclusion Criteria1

  • chromosomal deletion proven by FISH examination
Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGmethylphenidate, fluoxetin, risperidone

first cognitive evaluation without methylphenidate,second cognitive evaluation with methylphenidate

Locations(1)

Schneider Children's Mediac Center of Israel

Petah Tikva, Israel

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00768820

Related Trials

Defining the Brain Phenotype of Children With Williams Syndrome

NCT011328851 location

Alpha Auditory Entrainment for Cognitive Enhancement and Sensory Hypersensitivity in Youth With Developmental Disorders

NCT062277801 location

Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

NCT0720946215 locations

Speech-in-noise Perception in Autism and Fragile X

NCT060885891 location

Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG- Infant

NCT065602421 location